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1. Introduction
  Leishmaniasis is endemic in 88 countries with incidence 
rate of 1.5-2 million; the most common form of leishmaniasis 
is cutaneous leishmaniasis (CL) with 1.5 million new cases 
per year[1,2]. 90% of cutaneous leishmaniasis are reported 
from Iran, Afghanistan, Algeria, Iraq, Saudi Arabia, and 
Syria in the Old World; and Bolivia, Brazil, Colombia, and 
Peru in the New World[3]. 
  In Iran, zoonotic CL (ZCL) and anthroponotic CL (ACL) are 
caused by Leishmania major (L. major) and Leishmania 
tropica (L. tropica), respectively. In recent years new 
foci of CL are reported from different parts of Iran[4,5]. 
Geographically prevalence of the disease is due to different 
factors which the most important ones are suitable climate 
conditions and related vectors and reservoirs[6]. In most of 
the cases, the lesion(s) heal after a few months to one year, 
but in some cases the lesion might last long[7]. In order to 
achieve effective control of CL, identification of Leishmania 
species is important[8]. The Leishmania species are the 
same in terms of morphology and the microscopically 
identification of Leishmania using direct smear and culture 
is impossible, also epidemiological and clinical findings 
are not sufficient to achieve this purpose[9-11]. Previously 
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identification of isolates mostly was depend upon traditional 
methods such as epidemiological characteristics of the 
disease, etc which are not definite and perfect[11]. 
  Differentiations among species require molecular or 
biochemical techniques such as PCR and isoenzymes 
analysis[11]. Biochemical methods are lengthy, complicated 
and expensive procedure, so nowadays molecular methods 
are more useful[12-15].
  PCR as one of the molecular method has been broadly 
used for the detection and identification of Leishmania 
species in CL, visceral leishmaniasis and other forms of the 
disease[11,16].
  CL is considered as one of the health problems in some 
provinces of Iran, including Lorestan. 
  According to the reports presented from 2006 to 2008, 
191(63.66%), 32 (23.36%) and 19 (33.33%) cases of CL out 
of 300, 137 and 57 cases, respectively, were due to local 
transmission[17,18]. In 2006 an epidemic of the disease 
occurred in Lorestan. Since Lorestan is one of the areas of 
endemic for CL but the species of Leishmania so far was 
unknown, identification of species, in order to select an 
appropriate control measure against reservoirs, vectors and 
also to treat the patient appropriately is necessary. So the 
aim of present study was to identify the parasite species 
using PCR.
2. Materials and methods
2.1. Study area
  This descriptive study was conducted from May 2009 to 
March 2011 in Lorestan province which is located between 
valleys of Zagros Mountain at the west of Iran covers 
an area of 28.392 km2. The population of the province 
is approximately 1.6 million. Lorestan province is a 
mountainous region. Climatically, the province is divided 
into three parts: the mountainous regions that experience 
cold winter and moderate summer. In the central region, 
the spring season begins from mid-February and lasts till 
about mid May. The southern area is under the influence of 
the warm air currents of Khuzestan province which has a hot 
summer and relatively moderate winter. 
2.2. Sample collection
  A clinical history was completed to record the necessary 
information such as name, age, sex, sites of ulcer on the 
body, address, data and place of acquiring the disease, 
previous travel history and location of the study. Diagnosis 
was done by direct smear and/or culture.
2.3. DNA extraction
  Samples were taken of 62 patients that referred to the 
Health centers in different cities of Lorestan province such 
as Poldokhtar, Kouhdasht, Nourabad, Doroud and Broujerd 
which the existence of parasite confirmed using direct 
dermal lesion smear and then grown in NNN and mass 
cultured in RPMI 1640 cell culture medium enriched with 
10% fetal bovine serum. 
  Genomic DNA was extracted from cultured promastigotes 
using DNeasy Tissue Kit (Qiagen, Courtaboeuf, France) in 
accordance with the manufacturer’s protocol. The extracted 
DNA was stored at -20 曟 until use.
 
2.4. PCR reaction
  ITS primers were used according to the previous study[12] 
with minor modifications. The PCR conditions consisted of 
one initial denaturing cycle at 94 曟 for 5 min, followed by 
30 cycles of 94 曟  for 30 s, 56 曟 for 30 s , 72 曟  for 40 s and 
finally 1 cycle of 72 曟 for 5 min. At the end, PCR products 
were analyzed using 1.5% agarose gel electrophoresis.
  Standard strains of L. major (MRHO/IR/75/ER) and L. tropica 
(MHOM/IR/01/yaza) were used as positive controls. Expected 
PCR products of L. major and L. tropica were 626 bp and 485 
bp, respectively.
  The study was approved by the Medical Research Ethics 
Committee of Lorestan University of Medical Sciences.
2.5. DNA sequencing
  PCR products were sequenced by dideoxy chain 
termination method. NCBI site was used to draw the 
phylogeny trees of L. major and L. tropica.
3. Results 
  Out of 62 patients, 26 (41.94%) were females and 36 (58.06%) 
were males. Patients’ age was between 1 to 70 years (Table 1).
The number of lesion was one lesion in 42 (67.7%) of the 
patients, two lesions in 12 (19.4%), three lesions in 5 (8.1%), 
four lesions in 1 (1.6%)and six lesions in 2 (3.2%) of the 
patients. Most of the patients were from Poldokhtar city with 
a total of 43 (69.4%) (Table 2).
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Table 1
Distribution of cutaneouse leishmaniasis cases by age, Lorestan, Iran, 
April 2009 to March 2011.
Number of case (%) Age group (year)
  6 (9.68)   1-10 
10 (16.13) 11-20 
16 (25.81) 21-30 
14 (22.58) 31-40 
  8 (12.90) 41-50 
  4 (6.45) 51-60 
  4 (6.45) 61-70 
62 (100) Total 
Table 2
Characterization of Leishmania species isolated from human cutaneous 
lesions using PCR in Lorestan, Iran, April 2009 to March 2011.
Infected cities
Number of cases (%)
Total
L. major L. tropica
Broujerd    1 (5.9) 2 (4.5) 3 (4.8)
Poldokhtar      6 (35.3) 37 (82.2) 43 (69.4)
Nourabad      9 (52.9) 1 (2.2) 10 (16.1)
Doroud 0 (0) 1 (2.2) 1 (1.6)
Kouhdasht    1 (5.9) 4 (8.9) 5 (8.1)
Total   17 (100) 45 (100) 62 (100)
  After ITS-PCR, according to the pattern of electrophoresis, 
out of 62 samples, 45 (72.6%) had an amplification produced 
fragment of 485 bp and 17 (27.4%) a 626 bp band that 
were similar to L. tropica and L. major reference strains, 
respectively (Figure 1).
1        2       3        4        5      6      7       8       9      10     11
626 bp
485 bp
600 bp
500 bp
400 bp
Figure 1. Agarose gel electrophoresis of PCR amplification for 
identification of Leishmania species. 
Lane 1, 11: 100 bp DNA ladder marker; Lane 2: Reference strain of 
L. tropica; Lane 3: Reference strain of L. major; Lane 4,5: Negative 
controls; Lane 6-8: L. tropica isolates; Lane 9,10: L. major isolates.
  
  Among the patients, 12 (19.35%) had history of travel to 
other provinces and 50 (80.65%) of the patients had no 
history of travel in the past year. From 50 patients resident 
of Lorestan, 41 (82%) infected with L. tropica and 9 (18%) with
L. major.
  Nucleotide sequence data reported here have been 
submitted to the GenBank database with accession numbers, 
L. tropica JX104546 and L. major JX025361. The phylogeny 
trees of L. major and L. tropica are shown in Figure 2 and 
Figure 3.
Figure 2. The phylogeny tree of L. tropica (Accession number 
JX104546)
 
Figure 3. The phylogeny tree of L. major (Accession number 
JX025361).
4. Discussion
  CL is a major public health problem in 17 of 30 provinces 
in Iran[4]. The current study was performed using PCR 
for the first time in the Lorestan province to determine of 
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Leishmania species.
  Since there are differences between the strategies of 
prevention and control against ACL and ZCL, to select an 
appropriate control measure the identification of the species 
is crucial[13]. The aim of this study was to identify the 
Leishmania species isolated from CL patients. The results 
of this research could the useful data for more accurate 
prevention programs.
  Before the advent of new techniques, there were problems 
with traditional identification methods such as clinical 
signs, epidemiological characteristics[11].
  CL is reported in several provinces of Iran and 
identification of the species in some of the foci was done 
using PCR method. For example, in rural area in Kerman 
province, it was determined that the causative agent of CL 
was L. major using RAPD-PCR[19].
  In another study on the cutaneous ulcers in Mashhad, 
using   ITS-PCR it has been determined that L. tropica was 
the dominant species[12]. In another study in Mashhad using 
PCR-RFLP, it was proven the dominance of L. tropica[20]. 
Also a study on the patients with scar in rural areas in Shiraz 
using Nested PCR has shown that the dominant species was 
L. major[21]. In order to identify Leishmania species using 
Nested-PCR, a study on the samples collected from 100 
patients with CL was performed in Shush city in Khuzestan 
province and shown that the predominant species was L. 
major[22]. In other countries, the molecular techniques 
were used to identify Leishmania species in the patients, 
reservoir and vectors. For example, in Morocco detection 
of Leishmania parasites in the skin biopsies was performed 
using PCR and showed that the method is highly sensitive 
(84.6%)[23]. In Venezuela, Leishmania species was identified 
in the sand flies using Multiplex-PCR[24]. In Brazil, detection 
of Leishmania parasite in biopsies from 109 patients with 
CL using PCR was shown that patients were infected with 
Leishmania braziliensis[25].
  In current study, 62 samples of cutaneous lesion were 
assessed by PCR in order to identify Leishmania species 
in Lorestan province. Among them, 50 samples were for 
residence of the province with no history of travel in at least 
a year prior to the onset and both L. tropica and L. major 
were identified from the collected samples and L. tropica 
was prodominant. Since the vectors of these two species are 
different and ACL is the main reservoir, identification of 
species is important for control and treatment. Due to drug 
resistance in 10 to 15 percent of CL within one province of 
Iran, therefore an appropriate treatment of all the patients 
in case of ACL is necessary[26]. In the other hand there are 
numerous ancient sites including the historic castle Falak_
al_aflak, 1 700 years old, which attracts tourists to the area 
of Lorestan province so special attention should be made to 
clearly define which parts of the province is endemic. 
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